Background In a Caucasian population, the prevalence and incidence of hypertension, renal function and large artery stiffness were significantly correlated with polymorphisms in the genes encoding the angiotensinconverting enzyme (ACE I/D), aldosterone synthase (2C344T) and the cytoskeleton protein AE-adducin (Gly460Trp).
Introduction
We recently found in a Caucasian population that blood pressure, the prevalence and incidence of hypertension [1] , renal function [2] and stiffness of the femoral and carotid arteries [3] , were significantly correlated with polymorphisms in the genes encoding the angiotensinconverting enzyme (ACE I/D), aldosterone synthase (CÀ344T) and the cytoskeleton protein AE-adducin (Gly460Trp). Homozygous carriers of the ACE D allele showed a higher incidence of hypertension than the other ACE genotypes. The incidence of hypertension was further increased in ACE DD homozygotes who also carried the AE-adducin 460Trp allele [1] . In crosssectional analyses, systolic blood pressure and the prevalence of hypertension were significantly elevated among subjects who carried both the AE-adducin 460Trp and the aldosterone synthase À344T alleles [1] . Furthermore, serum creatinine and proteinuria were slightly, but significantly higher and creatinine clearance was lower in subjects having both the AE-adducin 460Trp and ACE D alleles [2] . Large artery stiffness was significantly related to the ACE I/D genotype, but this relationship depended on vascular territory and genetic background [3] . Carriers of the ACE D allele compared with II homozygotes, have systemically increased ACE levels, which may promote the local generation of angiotensin II [4, 5] and hence vascular growth [6] . Intima-media thickening of the large arteries is a precursor of frank atherosclerosis and a harbinger of cardiovascular complications [7] [8] [9] .
The hypothesis underlying previous studies was that interactions between the three candidate genes might raise blood pressure and influence renal function via stimulation of sodium reabsorption in the kidney and chronic expansion of the circulating fluid volume [1] . These mechanisms may be sufficient to engender structural changes in the wall of large arteries. To test this hypothesis, the effects of the three aforementioned candidate genes were investigated, alone and combined, on the intima-media thickness of the elastic common carotid artery and the muscular femoral artery in a subgroup of subjects enrolled in our population study [1] .
Methods

Study population
The Flemish Study on Environment, Genes and Health Outcomes (FLEMENGHO) started in 1985. Its protocol was approved by the Ethics Committee of the University of Leuven, Belgium. From August 1985 until November 1990, a random sample of the households living in a geographically defined area of Northern Belgium was recruited [10] . To further investigate the role of genetic factors, from June 1996 until January 1999, the study population was enlarged with nuclear families, including children who were at least 10 years old, using the former participants as index persons. The participants or their parents gave informed consent. The participation rate among all subjects contacted was 64.3% [1] [2] [3] .
For the present study, carotid and femoral intimamedia thickness were measured in 392 subjects. Because of missing values of potentially important confounding variables, 12 subjects were excluded, leaving 380 persons for analysis.
Fieldwork
Before the participants were examined at the field centre, they refrained from smoking, heavy exercise, and drinking alcohol or caffeine-containing beverages for at least 3 h. Their blood pressure was measured five times consecutively after they had rested for 5 min and were sitting. Hypertension was diagnosed if the average of the five blood pressure readings was at least 140 mmHg systolic or 90 mmHg diastolic, or when the subjects were on antihypertensive medication. On a separate day, validated [11] oscillometric SpaceLabs 90202 or 90207 monitors (Redmond, Washington, USA) fitted with the same cuff size as for the conventional measurements, were programmed to obtain readings with an interval of 20 min for at least 12 h between 0800 and 2200 h. Every month, the recorders were checked for accuracy against a mercury column. The mean daytime blood pressure was calculated from unedited recordings with weights according to the time interval between successive readings [12] . White-coat hypertension was assumed to be present if patients who were hypertensive on conventional measurement and who were untreated, had a daytime ambulatory blood pressure lower than 135 mmHg systolic and 85 mmHg diastolic [12, 13] . A venous blood sample was obtained for measurement of serum lipids, blood glucose and genotypes.
The same observer (E.J.B.) performed all vascular measurements, using a wall-tracking ultrasound system with a 7.5 MHz probe [14] . She recorded the intimamedia thickness of the right common carotid artery 2 cm proximal of the bulb and that of the common femoral artery 1 cm proximal of the bifurcation into the profound and superficial branches. Simultaneously with the vascular measurements, blood pressure was recorded at 3 min intervals at the right upper arm with a semi-automated device (Dinamap 845, Applied Medical Reseach Corporation, Tampa, Florida, USA). The same operator measured off-line, the distances from the adventitia-media boundary of the near wall to the lumen-intima and media-adventitia interfaces of the far wall [15] . The intima-media thickness was computed as the mean difference between these distances measured over three separate intervals of 5.2 s, which on average included 15 heart cycles. An atherosclerotic plaque was defined as a distinct area where the intima-media encroached into the vessel lumen and where its thickness was at least 50% greater than that of the adjacent sites [16] . When present, atheromatous plaques were included in the measurements of intima-media thickness. Repeatability was determined in 10 subjects, as previously described [15] . For the carotid intima-media thickness, the repeatability coefficients were 29 ìm below age 40 years and 40 ìm in older subjects. For the femoral artery, these coefficients were 41 and 46 ìm, respectively. For all ages combined, the intra-observer intrasession coefficients of variability [17] amounted to (AE SD) 5.2 AE 1.7% for the common carotid artery and to 5.6 AE 4.6% for the femoral artery.
Determination of genotypes
Genomic DNA was extracted from peripheral blood. The ACE I/D polymorphism was detected, as described by Lindpaintner et al. [18] . All samples initially genotyped as DD underwent a second polymerase chain reaction (PCR) with insertion-specific primers [18, 19] . Allelic discrimination of the Gly460Trp AE-adducin polymorphism was carried out using a 59 nuclease assay [20] on an ABI Prism 7700 apparatus (Perkin Elmer, Norwalk, Connecticut, USA). The forward and reverse primers and the 460Gly and 460Trp probes employed in the TAQMan assay were 59-CGTCCACACCTTAGTCTTCGACTT-39, 59-GGAG AAGACAAGATGGCTGAACTC-39, 59-FAM-TTCCA TTCTGCCCTTCCTCGGA-TAMRA-39 and 59-TET TTCCATTCTGCCATTCCTCGGAATAMRA-39, respectively. Per 25 ìl, the PCR fluid contained 50 ng DNA, 300 nmol primers, 100 nmol FAM-probe and 50 nmol TET-probe. The amplification conditions were 508C for 2 min, 958C for 10 min, 958C for 15 s and 628C for 1 min for 40 cycles. For determination of the CÀ344T aldosterone synthase gene variants, PCR and subsequent genotyping were performed as described by Brand et al. [21] .
Statistical methods
For statistical analysis the SAS version 8.1 (SAS Institute, Cary, North Carolina, USA) and StatXact version 4.01 (Cytel Software Corporation, Cambridge, Massachusetts, USA) were used. Comparisons of means and proportions were performed with the standard normal z-test and Fisher's exact test, respectively. Significant co-variables of intima-media thickness were traced by stepwise linear regression. P-values for independent explanatory variables to enter and to stay in the model were set at $0.15. The presence of atheromatous plaques in relation to genotype was studied by multiple logistic regression. In multiple linear and logistic regression, the genotypes were first represented by dummy variables using the deviation from mean coding approach [22] , which does not imply any genetic hypothesis. In single-gene analyses in which independent hypotheses were tested, the AE-levels and confidence intervals were adjusted for multiple testing, using Bonferroni's method [23] . To formally test the prior hypothesis of genetic interactions between the three candidate genes [1] [2] [3] , dummy variables were also used, coded according to the absence or presence of the risk conferring alleles ACE D, AE-adducin 460Trp, and aldosterone synthase À344T. Because family members are more likely to share identical alleles than randomly selected subjects and to allow for the non-independence of the arterial phenotypes within families, the analysis was repeated, using generalized estimating equations [24] as implemented in the PROC GENMOD procedure [25] of the SAS package. In these analyses, we treated families as clusters and we applied a user-defined working correlation matrix, based on the intrafamilial intraclass correlation coefficients observed in our study subjects.
Results
Characteristics of the participants
The 380 participants included 188 men (49.5%) and 115 hypertensive patients (30.3%), of whom 47 were on one or more blood pressure-lowering drugs. Antihypertensive treatment included diuretics in 19 patients, drugs inhibiting the renin system in 39 subjects (n ¼ 28 for â-blockers, n ¼ 10 for angiotensin converting-enzyme inhibitors, and n ¼ 2 for angiotensin type-1 receptor blockers), and vasodilators in seven patients (n ¼ 5 for calcium-channel blockers, and n ¼ 2 for AEblockers). Overall, 18 subjects were taking lipid-lowering drugs. The daytime ambulatory blood pressure averaged 124.8 AE 9.9 mmHg systolic and 75.0 AE 7.9 mmHg diastolic in men. In women, these levels were 121.6 AE 10.5 mmHg and 73.6 AE 7.6 mmHg, respectively. Of 68 untreated hypertensive patients, 47 (69.1%) had white-coat hypertension.
The subjects ranged in age from 12 to 76 years (Table  1) . Carotid and femoral intima-media thickness increased with age ( Fig. 1 , P , 0.001). Carotid or femoral atheromatous plaques were present in 16 men (8.6%) and 12 women (6.2%). Among men, 57 (30.3%) were current smokers and 120 (63.8%) reported intake of alcohol. In women, these numbers were 48 (25.0%) and 72 (37.5%), respectively. A total of 17 women (8.9%) used oral contraceptives and none took hormonal replacement therapy.
Genotype and allele frequencies
The frequencies of the ACE (P ¼ 0.37), AE-adducin (P ¼ 0.84) and aldosterone synthase (P ¼ 0.16) genotypes did not deviate from Hardy-Weinberg equilibrium. Before (Table 2 ) and after adjustment for covariables, the relative risk of having atheromatous plaques was similar across all genotypes, regardless of whether single-gene effects or genetic interactions were tested.
Intima-media thickness
Stepwise regression analysis identified gender, age, body-mass index, mean arterial pressure, current smoking, serum low-density lipoprotein-cholesterol concentration, and use of antihypertensive medications as likely or significant determinants of the intima-media thickness of the carotid artery, femoral artery, or both (Table 3) . Because the correlation coefficient between carotid and femoral intima-media thickness was 0.33 (P , 0.001), all analyses were adjusted for the aforementioned co-variables.
The P-value for the t-to-enter of lipid-lowering treatment was 0.51 for the carotid artery and 0.005 for the femoral artery. However, the regression coefficients (AE SE) for current use of lipid-lowering drugs (coded 0 or 1) were positive (27.0 AE 40.4 and 180.8 AE 64.1) and therefore reflected bias-by-indication. Furthermore, the P-values for the t-to-enter were 0.29 or larger for the presence of white-coat hypertension and blood glucose concentration. Sensitivity analyses showed that accounting for the latter three variables did not affect the conclusions. Therefore, in the present analysis, these three covariables were not allowed for.
Both before (Fig. 2) and after adjustment for the above co-variables, intima-media thickness of the femoral, but not carotid, artery was significantly associated with ACE genotype. For both arteries, none of the singlegene associations with the AE-adducin or aldosterone synthase genotypes reached statistical significance.
In a further step of the adjusted analysis, it was observed that the effect of the ACE genotype on femoral intima-media thickness was confined to carriers of the AE-adducin 460Trp allele or the aldosterone synthase À344T allele. In the presence of the 460Trp allele, the mean intima-media thickness was 59 ìm lower than the population mean in II homozygotes of the ACE gene, whereas in DD homozygotes it was on average 86 ìm higher than the population mean (Fig.  3) . In carriers of the aldosterone synthase À344T allele, the corresponding deviations from the population mean amounted to À48 and 73 ìm (Fig. 4) . In the presence of both the AE-adducin 460Trp and aldosterone synthase À344T alleles, these quantities were À52 and 123 ìm, respectively (Fig. 5 ). Expressed as a percentage of the mean femoral intima-media thickness in the whole population, the differences between the II and DD homozygotes averaged 13.4% (95% CI 5.6-21.2%) in all subjects, 21.2% (8.0À34.5%) in carriers of the AEadducin 460Trp allele, 15.4% (4.1À26.8%) in subjects having the aldosterone synthase À344T allele, and 25.2% (10.7À39.7%) if the latter alleles were both present.
Similar results were obtained if 28 subjects with plaques at any arterial site (carotid or femoral) were excluded. In this restricted sample, the differences between II and DD homozygotes averaged 11.7% (4.7À18.7%). In 150 carriers of the AE-adducin 460Trp allele, in 279 carriers of the aldosterone synthase À344T allele, and in 123 carriers of both the 460Trp and À344T alleles, the differences between the II and DD homozygotes in the restricted group amounted to 18.3% (6.2À30.5%), 13.8% (3.6À24.0%) and 22.8% (9.4À36.2%), respectively. Values are given as numbers (%). y Fisher's exact test with Bonferroni's correction of the P-values was used to compare frequencies between subjects with and without atheromatous plaques. IMT, intima-media thickness; LDL, low-density lipoprotein; NS, non-significant (P-value for the t-to-enter into the model is presented). Ã Men were coded as 0 and women as 1. y P-value for the multiple partial correlation between IMT and both the linear and squared terms of age. Furthermore, the results were also confirmed after additional allowance for the non-independence of the intima-media thickness phenotype within families. The differences between the II and DD homozygotes averaged 12.5% (95% CI 3.7-21.3%; P ¼ 0.005) in all subjects, 22.5% (7.0À38.1%; P ¼ 0.005) in carriers of the AE-adducin 460Trp allele, 12.9% (1.2À4.6%; P ¼ 0.03) in subjects having the aldosterone synthase À344T allele, and 27.5% (9.9À45.6%; P ¼ 0.003) if the latter alleles were both present.
In further regression analyses in all subjects, the AEadducin and aldosterone synthase genotypes were represented by dummy variables coded 0 or 1 depending on the absence or presence of the 460Trp and À344T alleles and the ACE genotypes were coded as 0, 1 or 2 according to the number of D alleles. The three-way interaction terms for the carotid and femoral arteries had P-values of 0.76 and 0.045, respectively.
Discussion
In proximal elastic arteries hypertrophy of the wall is a marker of atherosclerosis, predominantly due to intima thickening, whereas in large or middle-sized muscular arteries this phenomenon mainly reflects remodelling of the media [26] . To the best of our knowledge, our study provides the first evidence of a synergism between the genes encoding ACE, AE-adducin and aldosterone synthase in relation to the intima-media thickness of the femoral artery. The mean differences between II and DD homozygotes of the ACE gene, expressed as a percentage of the population mean, amounted to 13.4% in all subjects. These differences averaged 21.2, 15.4 and 25.2%, respectively, if the AEadducin 460Trp allele, the aldosterone synthase À344T allele, or both alleles, were present. Less phenotypic precision when a dichotomous trait replaces a continuous one and the small number of cases (n ¼ 28), probably explain the null findings with regard to the presence of atheromatous plaques. Because of the sample size required [1] , blood pressure as an outcome variable in the present 380 subjects was not considered.
Few studies [27, 28] reported on the genetic factors influencing femoral intima-media width and no investigator found a significant and positive association with the ACE D allele. Several studies [27] [28] [29] [30] [31] [32] [33] [34] specifically addressed the possible relationship between the ACE I/ D polymorphism and carotid intima-media thickening. Most studies [29, [31] [32] [33] reported negative results. In the Vobarno population study, the ACE D allele was found to be associated with carotid intima-media Intima-media thickness of the carotid and femoral arteries by angiotensin-converting enzyme (ACE) genotype. Values are unadjusted means AE standard error. For each genotype the number of subjects is given.
thickening, but not with the presence of carotid atherosclerotic plaques [30] . In a Finnish population study, non-smoking DD homozygotes had a significantly greater carotid intima-media thickness than did those with the II or ID genotypes [35] . In the total population, this association was weaker and it was reported to be absent in current smokers. In Japanese subjects [36] , a positive correlation has been observed between the D allele and the presence of carotid plaques. In Chinese hypertensive subjects [34] , a positive correlation was observed between the D allele and carotid intima-media thickening, but not with left ventricular Intima-media thickness of the carotid and femoral arteries by angiotensin-converting enzyme (ACE) and AE-adducin genotypes. The measurements were adjusted for gender, age, age 2 , mean arterial pressure, body mass index, smoking, serum low-density lipoprotein-cholesterol concentration and intake of antihypertensive drugs. The results are expressed as deviations from the population mean with 95% confidence interval. For each combination of genotypes the number of subjects is given.
hypertrophy. Two quantitative reviews of the available literature [37, 38] also found significant associations between major atherosclerotic complications and the presence of the ACE D allele. However, no association between cardiovascular disease and the ACE I/D polymorphism was reported in a meta-analyses of studies in Caucasians [39] . Some studies of the carotid artery included genetic variants other than the ACE I/D polymorphism, such as the M235T polymorphism of the angiotensinogen gene [33] or the A1166C poly- Intima-media thickness of the carotid and femoral arteries by angiotensin-converting enzyme (ACE) and aldosterone synthase genotypes. The measurements were adjusted for gender, age, age 2 , mean arterial pressure, body mass index, smoking, serum low-density lipoprotein-cholesterol concentration and intake of antihypertensive drugs. The results are expressed as deviations from the population mean with 95% confidence interval. For each combination of genotypes the number of subjects is given.
morphism of the angiotensin-II receptor gene [31] . However, no study formally tested for synergism between these candidate genes in relation to intimamedia thickness or the presence of atherosclerosis.
The present findings concerning the femoral intimamedia thickness are in line with the blood pressure results in a cross-sectional analysis of 1461 subjects drawn from the same population [1] . Systolic blood pressure and the prevalence of hypertension were significantly elevated among subjects who carried both the AE-adducin 460Trp allele and the aldosterone synthase À344T allele. In a recently published casecontrol study [40] , a similar trend (P ¼ 0.10) was observed in as few as 129 hypertensive patients and 129 normotensive controls. The presence of the ACE D allele is associated with higher systemic ACE levels [4] , which probably stimulate the local generation of angiotensin II [5] . This may promote intima-media thickening. Hypertensive patients carrying the AE-adducin 460Trp allele, compared with those having the wildtype Gly460 variant, show an enhanced proximal tubular renal reabsorption of sodium [41] and experience larger blood pressure changes in response to sodium loading or diuretic treatment [19, 41, 42] . The presence of the À344T allele at the CÀ344T locus in the promoter area of the aldosterone synthase gene stimulates aldosterone synthesis independently of the regulation by angiotensin II and potassium [43] . The mutated AE-adducin and high aldosterone secretion, both acting through sodium retention, may possibly lead to chronic expansion of the extracellular fluid volume and increased blood pressure and may, via these intermediary mechanisms, induce compensatory structural changes in the wall of large muscular arteries.
Williams et al. [44] examined the interactions between seven polymorphic genetic markers at four candidate loci in relation to hypertension. In single-gene analyses, there were no significant differences between Intima-media thickness of the carotid and femoral arteries by angiotensin-converting enzyme (ACE) genotype in carriers of the AE-adducin 460Trp and aldosterone-synthase À344T alleles. The measurements were adjusted for gender, age, age 2 , mean arterial pressure, body mass index, smoking, serum low-density lipoprotein-cholesterol concentration and intake of antihypertensive drugs. The results are expressed as deviations from the population mean with 95% confidence interval. For each combination of genotypes the number of subjects is given.
normotensive and hypertensive subjects with respect to either allele or genotype frequencies. However, of 120 multilocus haplotypes, the distribution of 16 nonallelic combinations deviated significantly from random in the hypertensive patients, whereas among normotensive subjects no linkage disequilibrium was observed. This report [44] , in line with the authors' present and previous findings [1] [2] [3] , suggests that genetic interactions between multiple loci rather than single genes make up the genetic basis of cardiovascular disease and probably explain the inconsistencies between single-gene studies. Furthermore, crosssectionally and longitudinally measured phenotypes of the same trait, for instance blood pressure, may differ in their apparent genetic determination [1] . Environmental factors modulate the effects of the inherited genetic code. Genetic interactions may result in pleiotrophic effects according to the involved tissue type, as for instance in the present paper the intima-media of elastic as opposed to muscular arteries. These factors add further complexity to the genetic determination of multigenic cardiovascular disorders. Molecular biology may help bridging the gap between DNA sequencing and pathophysiological mechanisms and elucidate how cardiovascular disorders come about. For instance, further in-vitro studies should clarify whether the stimulation of the sodium pump in carriers of the AEadducin 460Trp allele is confined to renal tubular cells [41, 42] or is ubiquitously present, in particular in vascular smooth muscle cells. The actively regulated intracellular Na þ concentration may modulate the availability of free Ca 2þ ions, which enhance contractility and stimulate cell growth [45, 46] .
If confirmed, the present findings may have important clinical implications for the assessment of cardiovascular risk and the treatment of hypertension. Indeed, in the Angina Prognosis Study [9] carotid and femoral intima-media thickening and femoral plaques predicted the incidence of cardiovascular death and myocardial infarction and the need of revascularization procedures in unadjusted analyses involving 809 patients with coronary artery disease. After adjustment for sex, age, smoking, previous cardiovascular disease and lipid status, the risk of revascularization remained correlated with femoral intima-media thickness and the presence of atherosclerotic plaques in the femoral artery. After adjustment for the same co-variables, carotid intima-media thickness failed to predict any cardiovascular event, but the presence of carotid plaques predicted (P ¼ 0.056) the risk of cardiovascular death or myocardial infarction.
Conclusion
Our findings suggest that intima-media thickness of large muscular arteries, such as the femoral artery, is influenced by synergism between the genes encoding ACE, AE-adducin and aldosterone synthase.
